Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Numerator:

Net loss	$	(137,311)	$	(198,147)	$	(267,843)	$	(419,824)
Denominator:
Weighted average common shares outstanding—basic and diluted	150,636,620		102,372,820		149,134,255		102,159,294
Net loss per share — basic and diluted	$	(0.91)	$	(1.94)	$	(1.80)	$	(4.11)

Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:


	As of June 30,
	2026	2025
Options to purchase common shares	20,375,534	15,671,561
Warrants to purchase common shares	—	294,195
Restricted share units	899,579	1,397,184
Total	21,275,113	17,362,940